These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36848235)

  • 21. ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy.
    Eby KG; Rosenbluth JM; Mays DJ; Marshall CB; Barton CE; Sinha S; Johnson KN; Tang L; Pietenpol JA
    Mol Cancer; 2010 Apr; 9():95. PubMed ID: 20429933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.
    Roth J; König C; Wienzek S; Weigel S; Ristea S; Dobbelstein M
    J Virol; 1998 Nov; 72(11):8510-6. PubMed ID: 9765388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
    Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
    Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
    Zaika AI; Kovalev S; Marchenko ND; Moll UM
    Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
    Costanzo A; Merlo P; Pediconi N; Fulco M; Sartorelli V; Cole PA; Fontemaggi G; Fanciulli M; Schiltz L; Blandino G; Balsano C; Levrero M
    Mol Cell; 2002 Jan; 9(1):175-86. PubMed ID: 11804596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cabin1 restrains p53 activity on chromatin.
    Jang H; Choi SY; Cho EJ; Youn HD
    Nat Struct Mol Biol; 2009 Sep; 16(9):910-5. PubMed ID: 19668210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A possible role of p73 on the modulation of p53 level through MDM2.
    Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
    Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
    Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
    Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ING5 is a Tip60 cofactor that acetylates p53 in response to DNA damage.
    Liu N; Wang J; Wang J; Wang R; Liu Z; Yu Y; Lu H
    Cancer Res; 2013 Jun; 73(12):3749-60. PubMed ID: 23576563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
    J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene.
    Bagchi D; Bagchi M; Stohs SJ
    Mol Cell Biochem; 2001 Jun; 222(1-2):149-58. PubMed ID: 11678597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.
    Wu D; Ozaki T; Yoshihara Y; Kubo N; Nakagawara A
    J Biol Chem; 2013 Jan; 288(2):1353-64. PubMed ID: 23148227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. USF1 defect drives p53 degradation during
    Costa L; Corre S; Michel V; Le Luel K; Fernandes J; Ziveri J; Jouvion G; Danckaert A; Mouchet N; Da Silva Barreira D; Torres J; Camorlinga M; D'Elios MM; Fiette L; De Reuse H; Galibert MD; Touati E
    Gut; 2020 Sep; 69(9):1582-1591. PubMed ID: 31822580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.
    Nozaki M; Tada M; Kashiwazaki H; Hamou MF; Diserens AC; Shinohe Y; Sawamura Y; Iwasaki Y; de Tribolet N; Hegi ME
    Brain Pathol; 2001 Jul; 11(3):296-305. PubMed ID: 11414472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event.
    Rehemtulla A; Taneja N; Ross BD
    Mol Imaging; 2004 Jan; 3(1):63-8. PubMed ID: 15142413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
    Mondal N; Parvin JD
    Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistoselective sequencing (IHSS) of p53 tumor suppressor gene in human oesophageal precancerous lesions.
    Shi ST; Feng B; Yang GY; Wang LD; Yang CS
    Carcinogenesis; 1996 Oct; 17(10):2131-6. PubMed ID: 8895479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.